BASELINE LDL-C AND CLINICAL OUTCOMES WITH ADDITION OF EZETIMIBE TO STATIN IN 18,144 PATIENTS POST ACS

Robert P. Giugliano; Christopher P. Cannon; Michael A. Blazing; Jennifer A. White; Sabina A. Murphy; Andrew M. Tershakovec; Ming‐Shyan Lin; Robert M. Califf; Eugene Braunwald

doi:10.1016/s0735-1097(15)60004-3

Keywords

MedicineEzetimibeStatinInternal medicineLdl cholesterolBaseline (sea)CardiologyCholesterol

Affiliated Institutions

Related Publications

Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT

Erin A. Bohula , Robert P. Giugliano , Christopher P. Cannon +6 more

Background— Statins lower low-density lipoprotein cholesterol (LDL-C) and high-sensitivity C-reactive protein (hs-CRP); addition of ezetimibe to statins further reduces LDL-C an...

2015 Circulation 327 citations

Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines

Scott M. Grundy , James I. Cleeman , C. Noel Bairey Merz +6 more

The Adult Treatment Panel III (ATP III) of the National Cholesterol Education Program issued an evidence-based set of guidelines on cholesterol management in 2001. Since the pub...

2004 Circulation 6899 citations

Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy

Among patients with atherosclerotic cardiovascular disease and LDL cholesterol levels of less than 70 mg per deciliter (1.81 mmol per liter), there was no incremental clinical b...

2011 New England Journal of Medicine 2850 citations

Comparison of Once-Daily, niacin Extended-Release/lovastatin with standard doses of atorvastatin and simvastatin (the advicor versus other Cholesterol-Modulating agents trial evaluation [ADVOCATE])

Harold Bays , Carlos A. Dujovne , Mark E. McGovern +4 more

This study compared the relative efficacy of a once-daily niacin extended-release (ER)/lovastatin fixed-dose combination with standard doses of atorvastatin or simvastatin, with...

2003 The American Journal of Cardiology 153 citations

Comparison of an Immunoprecipitation Method for Direct Measurement of LDL-Cholesterol With Beta-Quantification (Ultracentrifugation)

Ishwarlal Jialal , Shaina V. Hirany , Sridevi Devaraj +1 more

A direct LDL cholesterol assay was evaluated using immunoprecipitation (Sigma Diagnostics, St. Louis, MO) with beta-quantification obtained by ultracentrifugation. Excellent int...

1995 American Journal of Clinical Pathology 36 citations

Publication Info

Year: 2015
Type: article
Volume: 65
Issue: 10
Pages: A4-A4
Citations: 7
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

BASELINE LDL-C AND CLINICAL OUTCOMES WITH ADDITION OF EZETIMIBE TO STATIN IN 18,144 PATIENTS POST ACS

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

OpenAlex

Cite This

APA Style

                            
                                
                                    Robert P. Giugliano, 
                                
                                    Christopher P. Cannon, 
                                
                                    Michael A. Blazing
                                
                                et al.
                            
                            (2015). 
                            BASELINE LDL-C AND CLINICAL OUTCOMES WITH ADDITION OF EZETIMIBE TO STATIN IN 18,144 PATIENTS POST ACS. 
                            Journal of the American College of Cardiology
                            , 65
                            (10)
                            , A4-A4.
                            https://doi.org/10.1016/s0735-1097(15)60004-3
                        

Identifiers

DOI: 10.1016/s0735-1097(15)60004-3